Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. is a company publicly traded on the NASDAQ Stock Market under the symbol AIMT. The company’s main activity sector is Health Care, sub-industry Major Pharmaceuticals. Aimmune Therapeutics, Inc. IPO year (Initial Public Offering – when its stocks were launched for trading) is 2015.
Below are the latest details regarding the Aimmune Therapeutics, Inc. trading on NASDAQ, like the stock price, change since previous trading date:Unfortunately, we could not get stock quote AIMT this time.
Aimmune Therapeutics, Inc. is only one of the many companies listed on the NASDAQ market. To trade Aimmune Therapeutics, Inc. shares, you need to get a contract with a broker – either an online broker or a company you know, like your bank. Some FX/Binary brokers also offer different stocks in their trading platform as CFDs. With these CFDs you do not own the stock, but rather leverage a position as to weather this stock will go up or down in a set interval. Please note that while CFDs can bring great winnings with limited capital, they also carry a high risk of losing all capital. Aimmune Therapeutics, Inc. (AIMT) stock trading at these CFD brokers is not guaranteed as each broker has a different list of stocks in their trading bucket.